-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Achilles Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and change rate from 2019 to Q2 2024.
- Achilles Therapeutics plc Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was $1.43M, a 17.7% increase year-over-year.
- Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2023 was $6.08M, a 16.9% decline from 2022.
- Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2022 was $7.32M, a 134% increase from 2021.
- Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2021 was $3.13M, a 490% increase from 2020.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)